TABLE 2.
In vivo parasitemia inhibition of P. yoelii 17XNL-infected mice treated with epirubicin for 4 days
| Group | Mean percentage parasitemia ± SD (% inhibitiona of parasite growth) |
||
|---|---|---|---|
| Day 3 | Day 5 | Day 7 | |
| Nontreated | 1.3 ± 0.8 | 1.7 ± 0.4 | 3.6 ± 1.5 |
| Treated with epirubicin (mg/kg) | |||
| 2 | 0.6 ± 0.4 (56) | 2.2 ± 1.5 (0) | 6.9 ± 5.3 (0) |
| 4 | 0.2 ± 0.2 (82) | 1.4 ± 1.2 (19) | 7.5 ± 6.1 (0) |
| 6 | 0.1 ± 0.1 (95) | 0.4 ± 0.3 (78) | 1.8 ± 1.3 (51) |
Values are expressed as mean percentage parasitemia inhibition relative to nontreated control. Data are means ± SD and are derived from three independent experiments (control, n = 18; 2 mg/kg, n = 16; 4 mg/kg, n = 15; 6 mg/kg, n = 16).